Gotowa bibliografia na temat „Cancer cells”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cancer cells”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Cancer cells"
Fernández-Lázaro, Diego, César Ignacio Fernández-Lázaro i Martínez Alfredo Córdova. "Cell Death: Mechanisms and Pathways in Cancer Cells". Cancer Medicine Journal 1, nr 1 (31.08.2018): 12–23. http://dx.doi.org/10.46619/cmj.2018.1-1003.
Pełny tekst źródłaSrivastava, A. N., Neema Tiwari, Shailendra Yadav i Suryakant . "LUNG CANCER STEM CELLS-AN UPDATE". Era's journal of medical research 4, nr 1 (1.06.2017): 22–31. http://dx.doi.org/10.24041/ejmr2017.4.
Pełny tekst źródłaFujimoto, Naohiro, Bin Han, Masayoshi Nomura i Tetsuro Matsumoto. "WS1-1-1 Nitrogen-Containing Bisphosphonates Inhibit the Growth of Renal Cell Carcinoma Cells(Renal Cell Cancer)". Japanese Journal of Urology 99, nr 2 (2008): 142. http://dx.doi.org/10.5980/jpnjurol.99.142_1.
Pełny tekst źródłaMAS, Bezerra, Ferreira LAM, Kawasaki-Oyama RS, Nascimento MCA, Cuzziol CI, Castanhole-Nunes MMU, Pavarino EC, Maniglia JM i Goloni-Bertollo EM. "Effectiveness of Hypoxia-Induced Accumulation of Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma". Cancer Medicine Journal 3, S1 (30.11.2020): 13–23. http://dx.doi.org/10.46619/cmj.2020.3.s1-1003.
Pełny tekst źródłaYin, Wen, Jialing Wang, Linling Jiang i Y. James Kang. "Cancer and stem cells". Experimental Biology and Medicine 246, nr 16 (5.04.2021): 1791–801. http://dx.doi.org/10.1177/15353702211005390.
Pełny tekst źródłaPratap, Dr Pushpendra D. "CANCER STEM CELLS IN CERVICAL CANCER AS BENEFICIAL GOALS AND BIOMARKERS: A COMPREHENSIVE". Era's Journal of Medical Research 10, nr 2 (grudzień 2023): 51–55. http://dx.doi.org/10.24041/ejmr2023.36.
Pełny tekst źródłaMoorthy, Rajesh Kannan, Chandhru Srinivasan, Sridharan Jayamohan, Mahesh Kumar Kannan, Siva Sankari Thirugnanam, Janaki Sankar Ganesh i Antony Joseph Velanganni Arockiam. "Knockdown of microRNA-375 suppresses cell proliferation and promotes apoptosis in human breast cancer cells". Indian Journal of Science and Technology 14, nr 43 (12.11.2021): 3199–209. http://dx.doi.org/10.17485/ijst/v14i43.1719.
Pełny tekst źródłaLee, Cheong J., Joseph Dosch i Diane M. Simeone. "Pancreatic Cancer Stem Cells". Journal of Clinical Oncology 26, nr 17 (10.06.2008): 2806–12. http://dx.doi.org/10.1200/jco.2008.16.6702.
Pełny tekst źródłaElgaly, Maher E., Mohamed E. El Ghareeb i Farha El shennawy. "Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovarian Cancer Cells in Vitro". International Journal of Trend in Scientific Research and Development Volume-2, Issue-5 (31.08.2018): 1783–88. http://dx.doi.org/10.31142/ijtsrd18182.
Pełny tekst źródłaSK, Deshmukh. "Immune Cells in the Tumor Microenvironment and Cancer Stem Cells: Interplay for Tumor Progression". Journal of Embryology & Stem Cell Research 2, nr 2 (2018): 1–2. http://dx.doi.org/10.23880/jes-16000109.
Pełny tekst źródłaRozprawy doktorskie na temat "Cancer cells"
Sarvi, Sana. "Small cell lung cancer and cancer stem cell-like cells". Thesis, University of Edinburgh, 2014. http://hdl.handle.net/1842/9542.
Pełny tekst źródłaFruka, Tayra. "An evaluation of cancer biomarkers in normal ovarian epithelial cells and ovarian cancer cell lines". University of the Western Cape, 2019. http://hdl.handle.net/11394/6920.
Pełny tekst źródłaIntroduction: Globally, there are over 190,000 new reported cases of ovarian cancers per annum. This comprises 3% to 4% of all cancers in women. Ovarian cancer is one of the leading causes of deaths in women. Ovarian cancer is the second most diagnosed gynaecological malignancy and over all the fifth cause leading to death among all types of cancer in the UK in 2004. More than 70% of epithelial ovarian cancers are diagnosed at an advanced stage. Consequently, the prognosis is poor and the mortality rate high. Thus, the survival rate is affected by how far the disease has progressed or spread. A dire need exists to identify ovarian cancer biomarkers, which could be used as good indicators of expression in ovarian cancer cells in vitro Aim: The aim of this study was to analyse selected cancer biomarkers, which are currently under intense investigation for their suitability to diagnose epithelial ovarian cancer at an early stage. These biomarkers were analysed in terms of their in vitro expression in normal epithelial cells and ovarian cancer cell lines, which allows for their genomic and proteomic classification. The expression analysis of each biomarker is related to the malignancy of a tumour and, therefore, advocates its use for potential future improvement of sensitive tumour markers. Methods: The primary human ovarian surface epithelial cell line (HOSEpiC), SKOV-3 cells and the OAW42 human epithelial ovarian tumour cell lines were used to evaluate the selected cancer biomarkers. Cells were cultured using appropriate media and supplements, and real-time quantitative polymerase chain reaction (RT-PCR) utilized to validate expression levels of the following genes: HDAC1, HDAC2, HDCA3, HDAC5, HDAC6, HDAC7, HDAC8, LPAR1, LPAR2, MUC16 and FOSL1, against normal housekeeping genes GAPDH and HPRT. In addition, immunocytochemistry was also used in the validation process of the aforementioned genes. Significance: ovarian cancer cells express gene signatures, which pose significant challenges for cancer drug development, therapeutics, prevention and management. The present study is an effort to explore ovarian cancer biomarkers to provide a better diagnostic method that may offer translational therapeutic possibilities to increase five- year survival rate. Results: HDAC5, HDAC6, LPAR1, LPAR2 and MUC16 expressed distinctively in ovarian cancers matched to other tissues or cancer types have already been identified by RT-QPCR and confirmed by immunocytochemistry and efforts to generate monoclonal antibodies to the other six genes (HDAC1, HDAC2, HDAC3, HDAC7, HDAC8 and FOSL1) encoded proteins are underway. Conclusions: here we provide strong evidence suggesting that HDAC5, HDAC6, LPAR1, LPAR2, except MUC16 are up regulated in ovarian cancer. These data were confirmed by examining Human Protein Atlas (HPA) databases, in addition to protein expression of HDAC5, HDAC6, LPAR1, LPAR2 and MUC16 in cells cytoplasm. For future prospective, using other techniques that assess the variant expression that could explain the release of these gene candidates into the circulation with serum tumour markers, and protein expression will be strengthened.
Sasaki, Naoya. "Alpha-fetoprotein-producing pancreatic cancer cells possess cancer stem cell characteristics". Kyoto University, 2012. http://hdl.handle.net/2433/157414.
Pełny tekst źródłaWong, Kit-man Sunny, i 王傑民. "Isolation and characterization of cancer stem cells in non-small cell lung cancer". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B47250665.
Pełny tekst źródłapublished_or_final_version
Pathology
Master
Master of Philosophy
Liu, Qing. "Curcumin induces cell inhibition in breast cancer cells". Click to view the E-thesis via HKUTO, 2006. http://sunzi.lib.hku.hk/hkuto/record/B38688608.
Pełny tekst źródłaLiu, Qing, i 劉晴. "Curcumin induces cell inhibition in breast cancer cells". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B38688608.
Pełny tekst źródłaOshima, Nobu. "Induction of Cancer Stem Cell Properties in Colon Cancer Cells by Defined Factors". Kyoto University, 2014. http://hdl.handle.net/2433/192147.
Pełny tekst źródłaKyoto University (京都大学)
0048
新制・課程博士
博士(医学)
甲第18547号
医博第3940号
新制||医||1006(附属図書館)
31447
京都大学大学院医学研究科医学専攻
(主査)教授 千葉 勉, 教授 野田 亮, 教授 武藤 学
学位規則第4条第1項該当
Coulson-Gilmer, Camilla Lucette. "Cancer stem cells and chemoresistance in ovarian cancer". Thesis, University of Leeds, 2017. http://etheses.whiterose.ac.uk/18470/.
Pełny tekst źródłaChoi, Mi-Yon. "P53 mediated cell motility in H1299 lung cancer cells". VCU Scholars Compass, 2010. http://scholarscompass.vcu.edu/etd/109.
Pełny tekst źródłaKapeleris, Joanna C. "Circulating tumour cells in non-small cell lung cancer". Thesis, Queensland University of Technology, 2022. https://eprints.qut.edu.au/228607/1/Joanna_Kapeleris_Thesis.pdf.
Pełny tekst źródłaKsiążki na temat "Cancer cells"
Farrar, William L., red. Cancer Stem Cells. Cambridge: Cambridge University Press, 2009. http://dx.doi.org/10.1017/cbo9780511605536.
Pełny tekst źródłaYu, John S., red. Cancer Stem Cells. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-280-9.
Pełny tekst źródłaRajasekhar, Vinagolu K., red. Cancer Stem Cells. Hoboken, NJ: John Wiley & Sons, 2014. http://dx.doi.org/10.1002/9781118356203.
Pełny tekst źródłaWiestler, O. D., B. Haendler i D. Mumberg, red. Cancer Stem Cells. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-70853-7.
Pełny tekst źródłaPapaccio, Gianpaolo, i Vincenzo Desiderio, red. Cancer Stem Cells. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7401-6.
Pełny tekst źródłaBapat, Sharmila, red. Cancer Stem Cells. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2008. http://dx.doi.org/10.1002/9780470391594.
Pełny tekst źródłaPat, Moyer Mary, i Poste George, red. Colon cancer cells. San Diego: Academic Press, 1990.
Znajdź pełny tekst źródłaPapaccio, Federica, i Gianpaolo Papaccio, red. Cancer Stem Cells. New York, NY: Springer US, 2024. http://dx.doi.org/10.1007/978-1-0716-3730-2.
Pełny tekst źródłaSharmila, Bapat, red. Cancer stem cells. Hoboken, N.J: John Wiley & Sons, 2008.
Znajdź pełny tekst źródłaL, Farrar William, red. Cancer stem cells. Cambridge: Cambridge University Press, 2009.
Znajdź pełny tekst źródłaCzęści książek na temat "Cancer cells"
Ishii, Hideshi, Naotsugu Haraguchi, Keisuke Ieta, Koshi Mimori i Masaki Mori. "Cancer Stem Cells: Gastrointestinal Cancers". W Stem Cells and Cancer, 155–63. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-933-8_12.
Pełny tekst źródłaSazeides, Christos, i Anne Le. "Metabolic Relationship Between Cancer-Associated Fibroblasts and Cancer Cells". W The Heterogeneity of Cancer Metabolism, 189–204. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_14.
Pełny tekst źródłaChowdhury, Suchandra, i Shyamasree Ghosh. "Cancer Stem Cells". W Stem Cells, 177–202. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-1638-9_7.
Pełny tekst źródłaLi, Ting, Christopher Copeland i Anne Le. "Glutamine Metabolism in Cancer". W The Heterogeneity of Cancer Metabolism, 17–38. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_2.
Pełny tekst źródłaJung, Jin G., i Anne Le. "Metabolism of Immune Cells in the Tumor Microenvironment". W The Heterogeneity of Cancer Metabolism, 173–85. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_13.
Pełny tekst źródłaJung, Jin G., i Anne Le. "Targeting Metabolic Cross Talk Between Cancer Cells and Cancer-Associated Fibroblasts". W The Heterogeneity of Cancer Metabolism, 205–14. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_15.
Pełny tekst źródłaHung, Jaclyn Y. "Cancer Stem Cells: Lung Cancer". W Stem Cells and Cancer, 177–84. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-933-8_14.
Pełny tekst źródłaDosch, Joseph, Cheong Jun Lee i Diane M. Simeone. "Cancer Stem Cells: Pancreatic Cancer". W Stem Cells and Cancer, 185–97. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-933-8_15.
Pełny tekst źródłaSaucedo, Leslie. "Cancer". W Getting to Know Your Cells, 79–84. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-30146-9_14.
Pełny tekst źródłaGeorgiadis, Konstantinos L., Kathryn Simpson, Mahmood Ayub, Ged Brady, Juan Valle, Claus Jorgensen i Caroline Dive. "Circulating Tumor Cells". W Pancreatic Cancer, 1325–60. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7193-0_62.
Pełny tekst źródłaStreszczenia konferencji na temat "Cancer cells"
Yoshimoto, T., T. Ishikawa, N. Matsuki, H. Fujiwara, Y. Imai, H. Ueno, M. Takeda i T. Yamaguchi. "Rheology of Cancer Cells With Different Metastatic Properties". W ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206593.
Pełny tekst źródłaSalmanzadeh, Alireza, Harsha Kittur, Michael B. Sano, Mark A. Stremler, P. Christopher Roberts, Eva M. Schmelz i Rafael V. Davalos. "Investigating Dielectrophoretic Signature of Mouse Ovarian Surface Epithelial Cells, Macrophages and Fibroblasts". W ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80872.
Pełny tekst źródłaKitagawa, H., N. Yamamoto, G. Kosaki i H. Yamazaki. "AN IMPORTANT ROLE OF CARBOHYDRATE MOIETIES ON CANCER CELL MEMBRANE GLYCOPROTEINS IN CANCER CELL-INDUCED PLATELET AGGREGATION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644667.
Pełny tekst źródłaZielinski, Rachel, Cosmin Mihai i Samir Ghadiali. "Multi-Scale Modeling of Cancer Cell Migration and Adhesion During Epithelial-to-Mesenchymal Transition". W ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53511.
Pełny tekst źródłaCohen-Armon, Malka. "An Unveiled Cell Death Mechanism Exclusive to Human Cancer Cells". W Cells 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/blsf2023021014.
Pełny tekst źródłaPatel, Sagar S., Ramesh Natarajan i Rebecca L. Heise. "Mechanotransduction of Primary Cilia in Lung Adenocarcinoma". W ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80435.
Pełny tekst źródłaTang, Xin, Tony Cappa, Theresa Kuhlenschmidt, Mark Kuhlenschmidt i Taher A. Saif. "A Novel Way to Characterize the Non-Specific Surface Adhesion of Cancer Cells and Understand Cancer Metastasis". W ASME 2009 International Mechanical Engineering Congress and Exposition. ASMEDC, 2009. http://dx.doi.org/10.1115/imece2009-11953.
Pełny tekst źródłaDi Donato, Marzia, Pia Giovannelli, Antimo Migliaccio i Gabriella Castoria. "New Approaches Targeting the Invasive Phenotype of Prostate Cancer-Associated Fibroblasts". W Cells 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/blsf2023021001.
Pełny tekst źródłaRegenbrecht, Christian. "Implication of Intra-Tumor Heterogeneity on Colorectal Cancer Response to MEK Inhibition". W Cells 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/blsf2023021019.
Pełny tekst źródłaBenammar, Sarra, Fatima Mraiche, Jensa Mariam Joseph i Katerina Gorachinova. "Glucose and Transferrin Liganded PLGA Nanoparticles Internalization in Non-Small Lung Cancer Cells". W Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0227.
Pełny tekst źródłaRaporty organizacyjne na temat "Cancer cells"
Alessa, Mohammed, Tayba Wahedi, Jumanah Alsairafi, Nouf Almatrafi, Wisal Shuaib, Johara Alnafie, Fatimah Alzubaidi i Soha Elmorsy. Prevalence of Thyroid cancer in Saudi Arabis: Systematic review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2022. http://dx.doi.org/10.37766/inplasy2022.9.0088.
Pełny tekst źródłaJones, Jonathan. Cell-Matrix Interactions in Breast Cancer Cells. Fort Belvoir, VA: Defense Technical Information Center, sierpień 1995. http://dx.doi.org/10.21236/ada300395.
Pełny tekst źródłaBrooks, James D. Single Cell Characterization of Prostate Cancer-Circulating Tumor Cells. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2013. http://dx.doi.org/10.21236/ada596639.
Pełny tekst źródłaBrooks, James B. Single Cell Characterization of Prostate Cancer Circulating Tumor Cells. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2011. http://dx.doi.org/10.21236/ada550987.
Pełny tekst źródłaQuinn, Timothy P. Killing Prostate Cancer Cells and Endothelial Cells with a VEGF-Triggered Cell Death Receptor. Fort Belvoir, VA: Defense Technical Information Center, luty 2003. http://dx.doi.org/10.21236/ada415526.
Pełny tekst źródłaQuinn, Timothy P. Killing Prostate Cancer Cells and Endothelial Cells With a VEGF-Triggered Cell Death Receptor. Fort Belvoir, VA: Defense Technical Information Center, luty 2004. http://dx.doi.org/10.21236/ada423810.
Pełny tekst źródłaQuinn, Timothy P. Killing Prostate Cancer Cells and Endothelial Cells with a VEGF-Triggered Cell Death Receptor. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 2005. http://dx.doi.org/10.21236/ada476353.
Pełny tekst źródłaMarkovic, Dubravka, i Edward P. Cohen. Treatment of Breast Cancer with Immunogenic Cells Transfected with DNA from Breast Cancer Cells. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2001. http://dx.doi.org/10.21236/ada396744.
Pełny tekst źródłaFridman, Rafael A. Cell Surface Regulation of Matrix Metalloproteinases in Breast Cancer Cells. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2000. http://dx.doi.org/10.21236/ada395379.
Pełny tekst źródłaFridman, Rafael A. Cell Surface Regulation of Matrix Metalloproteinases in Breast Cancer Cells. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2001. http://dx.doi.org/10.21236/ada396698.
Pełny tekst źródła